223 related articles for article (PubMed ID: 17523945)
1. Histamine in rheumatoid arthritis.
Adlesic M; Verdrengh M; Bokarewa M; Dahlberg L; Foster SJ; Tarkowski A
Scand J Immunol; 2007 Jun; 65(6):530-7. PubMed ID: 17523945
[TBL] [Abstract][Full Text] [Related]
2. Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis.
Dehlin M; Bokarewa M; Rottapel R; Foster SJ; Magnusson M; Dahlberg LE; Tarkowski A
PLoS One; 2008; 3(11):e3633. PubMed ID: 18982072
[TBL] [Abstract][Full Text] [Related]
3. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
4. Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis.
Rovensky J; Imrich R; Radikova Z; Simorova E; Greguska O; Vigas M; Macho L
Endocr Regul; 2005 Jan; 39(1):1-6. PubMed ID: 16107132
[TBL] [Abstract][Full Text] [Related]
5. Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis.
Pullerits R; Bokarewa M; Jonsson IM; Verdrengh M; Tarkowski A
Rheumatology (Oxford); 2005 Jan; 44(1):32-9. PubMed ID: 15367748
[TBL] [Abstract][Full Text] [Related]
6. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis.
Wittkowski H; Foell D; af Klint E; De Rycke L; De Keyser F; Frosch M; Ulfgren AK; Roth J
Ann Rheum Dis; 2007 Aug; 66(8):1020-5. PubMed ID: 17223658
[TBL] [Abstract][Full Text] [Related]
7. Melanoma inhibitory activity, a biomarker related to chondrocyte anabolism, is reversibly suppressed by proinflammatory cytokines in rheumatoid arthritis.
Vandooren B; Cantaert T; van Lierop MJ; Bos E; De Rycke L; Veys EM; De Keyser F; Bresnihan B; Luyten FP; Verdonk PC; Tak PP; Boots AH; Baeten D
Ann Rheum Dis; 2009 Jun; 68(6):1044-50. PubMed ID: 18633128
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
[TBL] [Abstract][Full Text] [Related]
9. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis.
Bokarewa M; Lindblad S; Bokarew D; Tarkowski A
Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma and joint tissue adrenomedullin concentrations in patients with rheumatoid arthritis compared to those with osteoarthritis.
Chosa E; Hamada H; Kitamura K; Eto T; Tajima N
J Rheumatol; 2003 Dec; 30(12):2553-6. PubMed ID: 14719193
[TBL] [Abstract][Full Text] [Related]
11. Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation.
Di Comite G; Rossi CM; Marinosci A; Lolmede K; Baldissera E; Aiello P; Mueller RB; Herrmann M; Voll RE; Rovere-Querini P; Sabbadini MG; Corti A; Manfredi AA
J Leukoc Biol; 2009 Jan; 85(1):81-7. PubMed ID: 18832606
[TBL] [Abstract][Full Text] [Related]
12. Synovial fluid expression of autoantibodies specific for RAGE relates to less erosive course of rheumatoid arthritis.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Rheumatology (Oxford); 2007 Aug; 46(8):1367-71. PubMed ID: 17569744
[TBL] [Abstract][Full Text] [Related]
13. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
[TBL] [Abstract][Full Text] [Related]
15. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
Park MC; Chung SJ; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
[TBL] [Abstract][Full Text] [Related]
16. Intra-articular injection of high molecular weight hyaluronan after arthrocentesis as treatment for rheumatoid knees with joint effusion.
Tanaka N; Sakahashi H; Sato E; Hirose K; Ishima T; Ishii S
Rheumatol Int; 2002 Aug; 22(4):151-4. PubMed ID: 12172954
[TBL] [Abstract][Full Text] [Related]
17. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis.
Senolt L; Pavelka K; Housa D; Haluzík M
Cytokine; 2006 Sep; 35(5-6):247-52. PubMed ID: 17079158
[TBL] [Abstract][Full Text] [Related]
18. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
[TBL] [Abstract][Full Text] [Related]
19. Is interleukin-18 useful for monitoring rheumatoid arthritis?
Bokarewa M; Hultgren O
Scand J Rheumatol; 2005; 34(6):433-6. PubMed ID: 16393763
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints.
Polzer K; Baeten D; Soleiman A; Distler J; Gerlag DM; Tak PP; Schett G; Zwerina J
Ann Rheum Dis; 2008 Nov; 67(11):1610-6. PubMed ID: 18174217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
